Product Information
FETZIMA 20-40 MG TITRATION PAK is a brand product labeled by Allergan, Inc., priced at $17.6066 per EA under NDC 00456220228. Its NADAC has been published 612 times since Nov 19, 2014.
FDA first approved this application on Jul 25, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Allergan, Inc.NDC
00456220228
Classification
Brand
Dosage Form
KIT
Route
ORAL
Effective Date
1/2/2026
Approval Type
New Drug (NDA)
FDA Application
NDA204168FDA Approved
7/25/2013
TE Code
AB
On Market Since
7/25/2013
Price Statistics
The NADAC for FETZIMA 20-40 MG TITRATION PAK has been published 612 times since Nov 19, 2014, and over the history we have for it it has risen 131.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.6066 per EA |
|---|---|
| All-time high | $17.6066 (Aug 19, 2026) |
| All-time low | $7.6146 (Nov 19, 2014) |
| 52-week high | $17.6066 |
| 52-week low | $16.7586 |
| Median price | $13.2673 |
| Average price | $13.1482 |
| Largest weekly change | +15.0% (Jul 8, 2015) |
| Weeks tracked | 612 |
| Tracking since | Nov 19, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the LEVOMILNACIPRAN HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FETZIMA 20-40 MG TITRATION PAK?
The current National Average Drug Acquisition Cost (NADAC) for FETZIMA 20-40 MG TITRATION PAK, manufactured by Allergan, Inc., is $17.6066 per EA (NDC 00456220228), effective Aug 19, 2026.
How has the price of FETZIMA 20-40 MG TITRATION PAK changed over time?
Over the history we have for it, the NADAC for FETZIMA 20-40 MG TITRATION PAK has risen 131.2%. It has been tracked across 612 weekly CMS publications since Nov 19, 2014.
What are the highest and lowest recorded NADAC prices for FETZIMA 20-40 MG TITRATION PAK?
Since Nov 19, 2014, the NADAC for FETZIMA 20-40 MG TITRATION PAK has ranged from a low of $7.6146 (Nov 19, 2014) to a high of $17.6066 (Aug 19, 2026), with a median of $13.2673 per EA.
Are there cheaper alternatives to FETZIMA 20-40 MG TITRATION PAK?
No other NADAC-published product currently shares the active ingredient and strength of FETZIMA 20-40 MG TITRATION PAK in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FETZIMA 20-40 MG TITRATION PAK?
FETZIMA 20-40 MG TITRATION PAK (NDC 00456220228) is labeled by Allergan, Inc., and CMS classifies it as a brand product.